William Blair & Company
MDLN

William Blair & Company’s Medline Inc MDLN Stock Holding History

William Blair & Company’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22M Sell
557,911
-607,519
-52% -$24.5M 0.06% 244
2026
Q1 		$51.9M Buy
1,165,430
+1,117,380
+2,325% +$49.3M 0.15% 139
2025
Q4 		$2.02M Buy
+48,050
New +$2.03M 0.01% 743

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

William Blair & Company's MDLN Position: Q2 2026 in Review

William Blair & Company reduced its Medline Inc (MDLN) stake by 52% in Q2 2026, selling an estimated $24.5M and leaving 557,911 shares worth $22M. The position accounts for 0.06% of the portfolio, ranked #244.

William Blair & Company first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. The position peaked at $51.9M in Q1 2026. 407 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • William Blair & Company held 557,911 shares of Medline Inc worth $22M as of Q2 2026.
  • William Blair & Company sold 607,519 Medline Inc shares in Q2 2026, an estimated $24.5M.
  • Medline Inc made up 0.06% of William Blair & Company's portfolio in Q2 2026, its #244 holding.
  • William Blair & Company first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • William Blair & Company's Medline Inc position peaked at $51.9M in Q1 2026.
  • 407 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.